As previously reported for ischemia-reperfusion injury [26], we found that administration of rhBCL2A1 failed to protect TLR2-null mice from sepsis-induced mortality, indicating that there is a requisite role for TLR2 signaling for the protective effect in vivo. The gene discussed is TLR2; the disease is ischemia reperfusion injury.